145 related articles for article (PubMed ID: 6608368)
1. Chronic myelodysplastic syndrome: short survival with or without evolution to acute leukaemia.
Weisdorf DJ; Oken MM; Johnson GJ; Rydell RE
Br J Haematol; 1983 Dec; 55(4):691-700. PubMed ID: 6608368
[TBL] [Abstract][Full Text] [Related]
2. Myelodysplastic syndromes: analysis of clinical and prognostic features in 96 patients.
van der Weide M; Sizoo W; Nauta JJ; Krefft J; Langenhuijsen MM
Eur J Haematol; 1988 Aug; 41(2):115-22. PubMed ID: 3165865
[TBL] [Abstract][Full Text] [Related]
3. Myelodysplastic syndromes. A clinical and pathologic analysis of 109 cases.
Foucar K; Langdon RM; Armitage JO; Olson DB; Carroll TJ
Cancer; 1985 Aug; 56(3):553-61. PubMed ID: 3891071
[TBL] [Abstract][Full Text] [Related]
4. Prognostic factors in the myelodysplastic syndromes: importance of initial data on peripheral blood counts, bone marrow cytology, trephine biopsy and chromosomal analysis.
Tricot G; Vlietinck R; Boogaerts MA; Hendrickx B; De Wolf-Peeters C; Van den Berghe H; Verwilghen RL
Br J Haematol; 1985 May; 60(1):19-32. PubMed ID: 3859319
[TBL] [Abstract][Full Text] [Related]
5. Myelodysplastic syndromes: a study of 101 cases according to the FAB classification.
Vallespi T; Torrabadella M; Julia A; Irriguible D; Jaen A; Acebedo G; Triginer J
Br J Haematol; 1985 Sep; 61(1):83-92. PubMed ID: 3863667
[TBL] [Abstract][Full Text] [Related]
6. Haematological features of primary myelodysplastic syndromes (PMDS) at initial presentation: a study of 118 cases.
Juneja SK; Imbert M; Jouault H; Scoazec JY; Sigaux F; Sultan C
J Clin Pathol; 1983 Oct; 36(10):1129-35. PubMed ID: 6619310
[TBL] [Abstract][Full Text] [Related]
7. [Analysis of 4 prognostic scoring systems in 197 myelodysplastic syndrome patients].
Rubio-Félix D; Giraldo MP; Perella M; Gimeno J; Franco E; Giralt M
Sangre (Barc); 1991 Dec; 36(6):463-9. PubMed ID: 1812580
[TBL] [Abstract][Full Text] [Related]
8. Evolution of acquired severe aplastic anaemia to myelodysplasia and subsequent leukaemia in adults.
de Planque MM; Kluin-Nelemans HC; van Krieken HJ; Kluin PM; Brand A; Beverstock GC; Willemze R; van Rood JJ
Br J Haematol; 1988 Sep; 70(1):55-62. PubMed ID: 3179229
[TBL] [Abstract][Full Text] [Related]
9. Proposals for the classification of the myelodysplastic syndromes.
Bennett JM; Catovsky D; Daniel MT; Flandrin G; Galton DA; Gralnick HR; Sultan C
Br J Haematol; 1982 Jun; 51(2):189-99. PubMed ID: 6952920
[TBL] [Abstract][Full Text] [Related]
10. Refractory cytopenia with multilineage dysplasia: further characterization of an 'unclassifiable' myelodysplastic syndrome.
Rosati S; Mick R; Xu F; Stonys E; Le Beau MM; Larson R; Vardiman JW
Leukemia; 1996 Jan; 10(1):20-6. PubMed ID: 8558932
[TBL] [Abstract][Full Text] [Related]
11. Prognostic factors in myelodysplastic syndromes: analysis of five scoring systems.
Rubio-Felix D; Giraldo P; Franco E; Gimeno J; Giralt M
Hematol Oncol; 1995; 13(3):139-52. PubMed ID: 7622144
[TBL] [Abstract][Full Text] [Related]
12. Myelodysplastic syndromes: analysis of morphological features related to the FAB-classification.
van der Weide M; Sizoo W; Krefft J; Langenhuijsen MM
Eur J Haematol; 1988 Jul; 41(1):58-61. PubMed ID: 2456946
[TBL] [Abstract][Full Text] [Related]
13. Myelodysplastic syndrome: a review from University Hospital, Kuala Lumpur.
Ng SC; Kuperan P; Bosco J; Menaka N
Singapore Med J; 1990 Apr; 31(2):153-8. PubMed ID: 2196685
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical detection of vascular endothelial growth factor (VEGF) in the bone marrow in patients with myelodysplastic syndromes: correlation between VEGF expression and the FAB category.
Wimazal F; Krauth MT; Vales A; Böhm A; Agis H; Sonneck K; Aichberger KJ; Mayerhofer M; Simonitsch-Klupp I; Müllauer L; Sperr WR; Valent P
Leuk Lymphoma; 2006 Mar; 47(3):451-60. PubMed ID: 16396768
[TBL] [Abstract][Full Text] [Related]
15. Philadelphia chromosome-negative chronic myelogenous leukaemia: a morphological reassessment.
Pugh WC; Pearson M; Vardiman JW; Rowley JD
Br J Haematol; 1985 Jul; 60(3):457-67. PubMed ID: 3860249
[TBL] [Abstract][Full Text] [Related]
16. [Retrospective study of 30 cases of myelodysplastic syndrome according to the French-American-British classification].
Piguet D; Schmidt PM; Delacrétaz F; Mermillod B
Schweiz Med Wochenschr; 1987 Jan; 117(2):61-6. PubMed ID: 3468610
[TBL] [Abstract][Full Text] [Related]
17. [Retrospective analysis of hemotherapy support in 226 cases of myelodysplastic syndromes].
Rubio-Félix D; Franco E; Giraldo P; Gimeno J; Cuesta I; Giralt M
Sangre (Barc); 1994 Apr; 39(2):117-20. PubMed ID: 8059289
[TBL] [Abstract][Full Text] [Related]
18. Myelodysplastic syndromes in patients under 50 years old: a single institution experience.
Breccia M; Mengarelli A; Mancini M; Biondo F; Gentilini F; Latagliata R; Mandelli F; Alimena G
Leuk Res; 2005 Jul; 29(7):749-54. PubMed ID: 15927670
[TBL] [Abstract][Full Text] [Related]
19. Prognostic relevance of serum thymidine kinase in primary myelodysplastic syndromes: relationship to development of acute myeloid leukaemia.
Musto P; Bodenizza C; Falcone A; D'Arena G; Scalzulli P; Perla G; Modoni S; Parlatore L; Valvano MR; Carotenuto M
Br J Haematol; 1995 May; 90(1):125-30. PubMed ID: 7786774
[TBL] [Abstract][Full Text] [Related]
20. [Chromosome abnormalities in myelodysplastic syndrome].
Fujita K; Mori H; Niikura H; Terada H; Shinohara T
Rinsho Byori; 1990 Aug; 38(8):911-6. PubMed ID: 2232253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
